AN2 Therapeutics
ANTX
#10006
Rank
NZ$54.37 M
Marketcap
NZ$1.98
Share price
5.56%
Change (1 day)
-19.49%
Change (1 year)

Earnings for AN2 Therapeutics (ANTX)

Earnings in 2025 (TTM): -NZ$64.78 Million

According to AN2 Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$94.97 Million, an increase over its 2023 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AN2 Therapeutics from 2021 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$64.78 Million-31.79%
2024 -NZ$94.97 Million-21.66%
2023 -NZ$0.13 Billion64.77%
2022 -NZ$73.57 Million95.89%
2021 -NZ$37.56 Million